Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Acute Myelogenous Leukemia
Drug:
cytarabine
(
DNA synthesis inhibitor
,
DNA-directed DNAP inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
10/14/2020
Excerpt:
Acute Myeloid Leukemia (Age ≥18 years): Therapy for Relapsed/Refractory Disease…LDAC (category 2B)...
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login